Reporting Date | Major Shareholder Name | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
05/10/2024 | VANGUARD GROUP INC | 281,682 | $619,700 | 61.74% | 2.06% |
05/01/2024 | CENTRIC WEALTH MANAGEMENT | 67,198 | $196,890 | 0.00% | 0.49% |
05/13/2024 | GEODE CAPITAL MANAGEMENT, LLC | 53,257 | $117,205 | 19.53% | 0.39% |
05/15/2024 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 45,700 | $100,540 | -39.63% | 0.33% |
05/20/2024 | VIRTU FINANCIAL LLC | 32,487 | $71,000 | 100.00% | 0.24% |
05/16/2024 | JANE STREET GROUP, LLC | 25,065 | $55,143 | 100.00% | 0.18% |
05/15/2024 | CITADEL ADVISORS LLC | 23,749 | $52,248 | -58.68% | 0.17% |
04/18/2024 | NAVITER WEALTH, LLC | 22,168 | $48,770 | 0.00% | 0.16% |
05/15/2024 | STATE STREET CORP | 21,300 | $46,860 | 0.00% | 0.16% |
05/14/2024 | NORTHERN TRUST CORP | 20,273 | $44,601 | 0.00% | 0.15% |
05/13/2024 | RENAISSANCE TECHNOLOGIES LLC | 19,000 | $42,000 | -82.91% | 0.14% |
05/10/2024 | BLACKROCK INC. | 16,992 | $37,383 | -1.26% | 0.12% |
04/15/2024 | WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 16,000 | $35,200 | 8.11% | 0.12% |
05/15/2024 | MORGAN STANLEY | 10,095 | $22,209 | 98.14% | 0.07% |
05/15/2024 | TOWER RESEARCH CAPITAL LLC (TRC) | 5,665 | $12,463 | 57.62% | 0.04% |
04/15/2024 | SUNBELT SECURITIES, INC. | 100 | $220 | -33.33% | 0.00% |
05/10/2024 | WELLS FARGO & COMPANY/MN | 91 | $200 | 31.88% | 0.00% |
05/10/2024 | JPMORGAN CHASE & CO | 38 | $84 | -51.28% | 0.00% |
04/09/2024 | MATHER GROUP, LLC. | 24 | $28 | 100.00% | 0.00% |
05/15/2024 | BANK OF AMERICA CORP /DE/ | 0 | $0 | -100.00% | 0.00% |
05/15/2024 | SABBY MANAGEMENT, LLC | 0 | $0 | -100.00% | 0.00% |
04/15/2024 | BROOKSTONE CAPITAL MANAGEMENT | 0 | $0 | -100.00% | 0.00% |
05/13/2024 | UBS GROUP AG | 0 | $0 | -100.00% | 0.00% |
05/13/2024 | XTX TOPCO LTD | 0 | $0 | -100.00% | 0.00% |
A. During the previous two years, 31 institutional investors and hedge funds held shares of MAIA Biotechnology, Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 281,682
Centric Wealth Management: 67,198
GEODE CAPITAL MANAGEMENT, LLC: 53,257
BRIDGEWAY CAPITAL MANAGEMENT, LLC: 45,700
Virtu Financial LLC: 32,487
JANE STREET GROUP, LLC: 25,065
A. 4.83% of MAIA Biotechnology, Inc. stock is owned by institutional investors.
A. Institutional investors have bought a total of 825,368 shares in the last 24 months. This purchase volume represents approximately $2.75 M in transactions.